IRIS
ARMENI, PATRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.605
NA - Nord America 2.795
AS - Asia 756
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 10
OC - Oceania 8
AF - Africa 3
Totale 8.187
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.640
IT - Italia 2.012
GB - Regno Unito 762
IE - Irlanda 708
UA - Ucraina 345
CN - Cina 304
DE - Germania 177
SE - Svezia 157
CA - Canada 149
FI - Finlandia 116
VN - Vietnam 108
HK - Hong Kong 107
FR - Francia 86
TR - Turchia 68
IN - India 54
KR - Corea 52
BG - Bulgaria 46
CZ - Repubblica Ceca 46
BE - Belgio 39
NL - Olanda 23
ES - Italia 20
CH - Svizzera 13
RO - Romania 12
IR - Iran 9
DK - Danimarca 8
EU - Europa 8
PH - Filippine 8
AT - Austria 7
PL - Polonia 7
JP - Giappone 6
IL - Israele 5
AU - Australia 4
JO - Giordania 4
MY - Malesia 4
NZ - Nuova Zelanda 4
SG - Singapore 4
TH - Thailandia 4
CL - Cile 3
NO - Norvegia 3
PT - Portogallo 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BR - Brasile 2
CO - Colombia 2
CR - Costa Rica 2
EE - Estonia 2
HU - Ungheria 2
ID - Indonesia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MX - Messico 2
PA - Panama 2
PE - Perù 2
PK - Pakistan 2
SI - Slovenia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AR - Argentina 1
AZ - Azerbaigian 1
BT - Bhutan 1
BY - Bielorussia 1
GE - Georgia 1
GR - Grecia 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
OM - Oman 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 8.187
Salva come PNG Salva come JPEG
Città #
Dublin 707
Southend 532
Chandler 484
Milan 452
Jacksonville 275
Ann Arbor 234
Rome 151
Toronto 135
Dearborn 128
Hong Kong 106
Dong Ket 104
New York 97
Beijing 94
Houston 93
Wilmington 80
Helsinki 75
Modena 66
Lawrence 64
Boston 63
Izmir 56
Seoul 52
Ashburn 48
Redwood City 41
Redmond 39
Brussels 37
Mountain View 34
Woodbridge 33
Boardman 30
Casorate Primo 30
Seattle 30
Los Angeles 27
Florence 26
Naples 23
Catania 22
Bari 21
Hefei 20
Duncan 18
Kunming 17
Nanjing 17
Bologna 16
Turin 15
Frankfurt am Main 14
Amsterdam 13
Cagliari 13
Genoa 13
Palombara Sabina 13
Torino 13
Bonndorf 12
Kocaeli 12
London 12
Pisa 12
Washington 12
Paris 11
Boydton 10
Busto Arsizio 10
Fairfield 10
Melendugno 10
Fremont 9
Jinan 9
Udine 9
Ottawa 8
Palermo 8
Dallas 7
Monza 7
Prague 7
Brno 6
Bucharest 6
Caserta 6
Casoria 6
Guangzhou 6
North Wales 6
Padova 6
Parma 6
Pavia 6
Pescara 6
Pomezia 6
Ravenna 6
Renton 6
Shenyang 6
Verona 6
Warsaw 6
Bacoli 5
Brescia 5
Carrara 5
Castellalto 5
Fuzhou 5
Gorgonzola 5
Lappeenranta 5
Matino 5
Messina 5
Nanchang 5
Napoli 5
Para 5
Taranto 5
Tokyo 5
Trieste 5
Amman 4
Auburn Hills 4
Bangkok 4
Berlin 4
Totale 5.033
Salva come PNG Salva come JPEG
Nome #
The cost of patients with chronic kidney failure before dialysis: results from the IRIDE observational study 379
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci 274
Digitalizzazione nelle tecnologie per la salute: impatto sui livelli di governo del SSN 269
Politiche del farmaco ed impatto sulla spesa: gli effetti di quindici anni di decentramento nel SSN, con un focus sull’adozione di forme alternative di distribuzione dei farmaci 264
PDTA per la chirurgia bariatrica: l'esperienza di 6 centri italiani 248
La spesa sanitaria: composizione ed evoluzione 245
I dispositivi medici in Italia: un settore, tanti mercati 205
Dinamiche economiche e performance del settore dei dispositivi medici in Italia 194
Programma Nazionale di HTA per dispositivi medici: prove tecniche di implementazione 165
Il governo regionale dell'assistenza farmaceutica e il suo impatto sulla spesa 159
L'acquisto di farmaci in Italia: l'effetto di approcci selettivi 154
De innovatione: the concept of innovation for medical technologies and its implications for healthcare policy-making 149
Real-world cost effectiveness of MitraClip combined with medical therapy versus medical therapy alone in patients with moderate or severe mitral regurgitation 145
The impact of HTA and procurement practices on the selection and prices of medical devices 142
PHP3 the simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study 141
Il governo dell'assistenza farmaceutica in Italia: possibili traiettorie di cambiamento 139
Il confronto dei sistemi sanitari in una prospettiva internazionale 132
The impact of generic reference pricing in Italy, a decade on 129
Diffusion without evidence: a study on high-risk medical devices 129
La rendicontazione e la remunerazione dei farmaci. Finalità, struttura e gestione del File F in nove Regioni italiane 125
The impact of generic reference pricing in Italy, a decade on 123
The future of Funds for Innovative Medicines: results from a Delphi Study 123
Cost-effectiveness and net monetary benefit of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the Italian National Health Service 122
A meta-analysis of MitraClip combined with medical therapy versus medical therapy alone for treatment of mitral regurgitation in heart failure patients 120
La spesa sanitaria: composizione ed evoluzione 116
Comparative effectiveness of Mitraclip plus medical therapy versus medical therapy alone in high-risk surgical patients: a comprehensive review 112
L'adozione dell'innovazione tecnologica da parte degli ospedali italiani: un'analisi dei fattori endogeni 111
When peers count: the effects on integrated type II diabetes care of communication within general practitioner-only subgroups in interprofessional primary care teams 110
The social burden and quality of life of patients with haemophilia in Italy 109
Il confronto dei sistemi sanitari in una prospettiva internazionale 107
Market access management by pharmaceutical companies in a complex environment: the Italian case study 106
Multi-professional primary care units: what affects the clinical performance of Italian general practitioners? 105
Social/economic costs and quality of life in patients with haemophilia in Europe 103
Il confronto dei sistemi sanitari in una prospettiva internazionale 100
Il confronto dei sistemi sanitari in una prospettiva internazionale 100
L'attività sperimentale sui dispositivi medici 98
La spesa sanitaria: composizione ed evoluzione 97
Mobile health divide between clinicians and patients in cancer care: results from a cross-sectional international survey 97
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe 97
What type of clinical evidence is needed to assess medical devices? 96
Il settore dei dispositivi medici in Italia. L’impatto delle politiche pubbliche sulle performance delle imprese 93
La spesa sanitaria: composizione ed evoluzione 93
Cost-benefit analysis in health care: the case of bariatric surgery compared with diet 92
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies 92
Social economic costs, health-related quality of life and disability in patients with Cri Du Chat syndrome 90
The simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study 89
The simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study 89
The simultaneous effects of pharmaceutical policies from payers’ and patients’ perspectives: Italy as a case study 88
I settori contigui alla sanità: struttura e performance delle imprese farmaceutiche, di dispositivi medici e delle farmacie in Italia 88
Il confronto dei sistemi sanitari in una prospettiva internazionale 84
A value-based revolution in health care: perspectives, challenges, and emerging approaches to defining and measuring the value of health care technologies 84
Programmi di early access dei farmaci e managed entry agreement in Italia: i risultati di un Focus Group (programmi di early access e managed entry agreement) 84
La spesa sanitaria: composizione ed evoluzione 79
Report n. 42 OSFAR (Osservatorio Farmaci) 78
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 75
Cost-utility analysis of esketamine for patients with treatment resistant depression in Italy 75
Implementation of value-based pricing for medicines 71
Cost-effectiveness and net monetary benefit of Olaparib maintenance therapy versus no maintenance therapy after first-line platinum-based chemotherapy in newly diagnosed advanced BRCA1/2-mutated ovarian cancer in the Italian National Health Service 71
La spesa sanitaria: composizione ed evoluzione 70
La spesa sanitaria: composizione ed evoluzione 67
La spesa sanitaria: composizione ed evoluzione 67
La spesa sanitaria: composizione ed evoluzione 65
Variations in non-prescription drug consumption and expenditure: determinants and policy implications 65
The invisible costs of obstructive sleep apnea (OSA): systematic review and cost-of-illness analysis 64
La spesa sanitaria: composizione ed evoluzione 61
Digital Twins in healthcare: is it the beginning of a new era of evidence-based medicine? A critical review 58
La spesa sanitaria: composizione ed evoluzione 55
Percutaneous mitral valve repair vs. stand-alone medical therapy in patients with functional mitral regurgitation and heart failure 45
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 44
Cost-minimization analysis to support the HTA of Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis of osteoporosis 44
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case 42
Reflections on the importance of cost of illness analysis in rare diseases: a proposal 35
The value of hearing aids for the Italian NHS: a cost-utility analysis 30
Use of resource modeling to quantify the organizational impact of subcutaneous formulations for the treatment of oncologic patients: the case of daratumumab in multiple myeloma 29
Collecting physicians' preferences on medical devices: are we doing it right? Evidence from Italian orthopedists using 2 different stated preference methods 24
Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention 22
Individual and team performanc: issues around the role of attributes and relationships among peers 22
Economic impact of a more extensive use of FENO testing on the Italian population with asthma 17
Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries 10
Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe 9
Cost-effectiveness analysis of HRD testing for previously treated patients with advanced ovarian cancer in Italy 8
Totale 8.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.008
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019136 0 0 0 0 0 0 0 0 0 0 44 92
2019/20201.572 71 33 83 95 160 193 225 163 183 168 74 124
2020/20211.206 63 88 41 116 121 81 105 60 132 103 108 188
2021/2022935 68 180 36 41 66 12 31 174 41 47 105 134
2022/20232.347 119 127 58 176 153 189 63 101 977 94 165 125
2023/20241.411 104 97 123 89 167 177 105 279 99 136 35 0
Totale 8.407